Clémence Thiers
Stock Analyst at Stifel Nicolaus
(4.67)
# 799
Out of 4,504 analysts
73
Total ratings
38.9%
Success rate
43.9%
Average return
Main Sectors:
Stocks Rated by Clémence Thiers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: NANO Nanobiotix S.A. | Reiterated: Buy | €25.00 → €45.00 | $35.56 | +26.55% | 10 | May 22, 2026 | |
| EPA: MAAT MaaT Pharma SA | Maintained: Buy | €19.00 | $2.78 | +583.45% | 18 | Mar 31, 2026 | |
| SWX: BIOV BioVersys AG | Reiterated: Buy | CHF 70.00 | $27.50 | +154.55% | 3 | Mar 31, 2026 | |
| BIT: PHIL Philogen S.p.A. | Maintained: Buy | €25.00 → €31.00 | $25.55 | n/a | 7 | Jun 25, 2025 | |
| EPA: ALSEN Sensorion SA | Maintained: Buy | €1.50 | $0.26 | n/a | 5 | Mar 14, 2025 | |
| EPA: IPN Ipsen S.A. | Maintained: Buy | €120.00 | $162.70 | n/a | 1 | Aug 17, 2023 | |
| EPA: VLA Valneva SE | Maintained: Buy | €7.50 → €9.00 | $2.18 | n/a | 2 | Aug 17, 2023 | |
| EPA: ADOC Adocia SA | Maintained: Buy | €12.00 | $3.74 | n/a | 3 | Jul 26, 2023 | |
| EPA: GBT Guerbet SA | Maintained: Hold | €18.00 | $8.73 | n/a | 4 | Jul 21, 2023 | |
| EPA: ALCOX Nicox S.A. | Maintained: Buy | €2.70 | $0.385 | n/a | 7 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | $4.28 | n/a | 3 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €91.00 | $18.80 | n/a | 4 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.25 | $2.85 | n/a | 1 | Dec 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €7.88 | $0.0822 | n/a | 1 | Dec 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.00 | $3.32 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | $54.70 | n/a | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €3.10 | $1.57 | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €370.00 | $320.50 | n/a | 1 | Apr 19, 2022 |
Nanobiotix S.A.
May 22, 2026
Reiterated: Buy
Price Target: €25.00 → €45.00
Current: $35.56
Upside: +26.55%
MaaT Pharma SA
Mar 31, 2026
Maintained: Buy
Price Target: €19.00
Current: $2.78
Upside: +583.45%
BioVersys AG
Mar 31, 2026
Reiterated: Buy
Price Target: CHF 70.00
Current: $27.50
Upside: +154.55%
Philogen S.p.A.
Jun 25, 2025
Maintained: Buy
Price Target: €25.00 → €31.00
Current: $25.55
Upside: n/a
Sensorion SA
Mar 14, 2025
Maintained: Buy
Price Target: €1.50
Current: $0.26
Upside: n/a
Ipsen S.A.
Aug 17, 2023
Maintained: Buy
Price Target: €120.00
Current: $162.70
Upside: n/a
Valneva SE
Aug 17, 2023
Maintained: Buy
Price Target: €7.50 → €9.00
Current: $2.18
Upside: n/a
Adocia SA
Jul 26, 2023
Maintained: Buy
Price Target: €12.00
Current: $3.74
Upside: n/a
Guerbet SA
Jul 21, 2023
Maintained: Hold
Price Target: €18.00
Current: $8.73
Upside: n/a
Nicox S.A.
Jul 19, 2023
Maintained: Buy
Price Target: €2.70
Current: $0.385
Upside: n/a
Jun 9, 2023
Maintained: Buy
Price Target: €17.00
Current: $4.28
Upside: n/a
May 30, 2023
Maintained: Buy
Price Target: €91.00
Current: $18.80
Upside: n/a
Dec 27, 2022
Maintained: Buy
Price Target: €5.25
Current: $2.85
Upside: n/a
Dec 27, 2022
Maintained: Buy
Price Target: €7.88
Current: $0.0822
Upside: n/a
Sep 23, 2022
Maintained: Buy
Price Target: €15.00
Current: $3.32
Upside: n/a
Sep 7, 2022
Maintained: Buy
Price Target: CHF 57.00
Current: $54.70
Upside: n/a
Aug 8, 2022
Downgraded: Hold
Price Target: €3.10
Current: $1.57
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: €370.00
Current: $320.50
Upside: n/a